Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Clinical trial NCT01612988 · TERMINATED

Trial details

NCT number: NCT01612988
Sponsor: French Innovative Leukemia Organisation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia (B-CLL)

Start date: 2012-07-01
Primary completion: 2015-12-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.